TITLE

PhRMA bans the branding

PUB. DATE
August 2008
SOURCE
Pharmaceutical Representative;Aug2008, Vol. 38 Issue 8, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the revision of the Pharmaceutical Research and Manufacturers of America (PhRMA) Code, which bans the distribution of noneducational branded leave-behinds and prohibits restaurant-based meals for doctors. The new code promises to have immediate and significant impact on drug representatives, and pharmaceutical representative training. It notes that the new guidelines strengthen earlier admonitions that companies should not provide any recreational or entertainment benefits.
ACCESSION #
33765713

 

Related Articles

  • Update.  // Medical Marketing & Media;Jan2006, Vol. 41 Issue 1, p24 

    The article reports on developments regarding companies in pharmaceutical industry in the U.S. Adair-Greene has been chosen U.S. agency of record by Stiefel Laboratories for the launch of Mimyx Cream for the treatment of atopic dermatitis. Ventiv's commercial services division and Archway...

  • On the Future of Drug Discovery. Campbell, Simon // Chemistry International;Sep/Oct2012, Vol. 34 Issue 5, p10 

    The article discusses the challenges facing the pharmaceutical industry due to revenue losses from lost patent protection. It is said that the industry has gone through reductions in research and development budgets, closure of research sites, and head count losses. It highlights the need for a...

  • Zone in on: MANUFACTURING. Van Arnum, Patricia // Pharmaceutical Technology;Apr2010, Vol. 34 Issue 4, p20 

    The article reports on the move of the Pharmaceutical Research and Manufacturers of America (PhRMA) to encourage Russian authorities about making policy changes to the proposed Russian Pharmaceutical Law. The PhRMA encourages the need to make such policy changes to maintain the country's strong...

  • KEY FACTORS IN THE RISING COST OF NEW DRUG DISCOVERY AND DEVELOPMENT. Dickson, Michael; Gagnon, Jean Paul // Nature Reviews Drug Discovery;May2004, Vol. 3 Issue 5, p417 

    Describes how the environment for pharmaceutical research and development (R&D) has changed over time and the effect of the changes on R&D cost, risk and time invested. Literature on the cost of drug discovery and development for new chemical entity; Efforts of the pharmaceutical industry to...

  • SAS Institute, Inc.  // Applied Clinical Trials;Dec2005, Vol. 14 Issue 12, p166 

    The article presents information on SAS Institute Inc., a company providing insights into pharmaceutical processes and technologies based on its expertise in analytics. The company provides standardized services in its respective fields. It possesses the de facto standard for clinical data...

  • BREAKING NEWS.  // Pharmaceutical Technology;Jan2007, Vol. 31 Issue 1, p22 

    The article offers world news briefs related to developments among pharmaceutical companies. Forest Laboratories Inc. would acquire the biopharmaceutical company Cerexa for $480 million. Schwarz Pharma has announced the resignation of CEO Patrick Schwarz-Schutte and U.S. subsidiary chief Klaus...

  • Metrics INC.  // Contract Pharma;2013 Corporate Capabilities & Contract Services Directory, p142 

    The article profiles Metrics Inc. It mentions that Metrics Inc. is a pharmaceutical research founded in 1994 which is a service provider of several pharmaceutical developments including clinical material manufacturing (CTM), first-time-in-man (FTIM) formulation, and quality pharmaceutical...

  • Report from: Pakistan. Wan, Jane // Pharmaceutical Technology;Jan2009, Vol. 33 Issue 1, p18 

    The article examines the market potential of pharmaceuticals in Pakistan. The country's Drug Control Organization revealed that the pharmaceutical sector has an annual growth rate of 10-15%. However, according to Jonathan Kimball, associate international vice-president of the and Manufacturers...

  • Transitioning to era of patient-centric care. Frederick, Jim // Drug Store News;8/13/2007, Vol. 29 Issue 10, p60 

    The article reports on the risk and reward of transformation of community pharmacies in the era of patient-centered care in the U.S. Drug dispensing and basic patient counseling will remain a crucial element of community pharmacy practice. On the other hand, the shift of pharmacies into a new,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics